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1 Introduction
Evidence for the participation of prostaglandins in
the mechanism of labor has been accumulating
over the last 10 years. Labor can be induced with
intravenous administration of PGF2a at term
[1, 2, 13] and even before term [3]. During spon-
taneous as well as oxytocin-induced labor PGE
and PGF concentrations in amniotic fluid rise
[4, 14] and plasma levels of 13,14-dihydro-15-
keto-PGF2 (PGFM) also rise [11] although not
until labor is in the active phase [6],
The failure to detect a singificant increase in
circulating PGFM levels in early labor [6, 8] has
cast some doubt on the importance of endogenous
prostaglandin F generation for the initiation of
labor. It is possible, however, that the uterine
sensitivity to PGF2a increases so much towards
term that to elicit uterine contractions PGFM
levels need not rise above normal levels. To investi-
gate this possibility the present study was under-
taken, the purpose of which was to correlate
plasma concentrations of PGF2o, and PGFM to
the increase in uterine activity when PGF2a is
infused i.v. at a low rate to pregnant women at
term.
2 Materials and methods
The study was conducted on 16 women in whom
induction of labor at term was indicated for
reasons given in Table I. All gave consent to have
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up to 7 blood samples drawn in the course of the
induction. Ten women were given PGF2a infusions
(Group B) and six controls were infused with
physiological saline (Group A) for six hours before
induction with PGF2a was began.
The clinical characteristics of the patients of both
groups are given in Table II. All had intact mem-
branes and the groups were similar with the excep-
tion of parity. All in group B were multiparous
whereas 4 of the 6 controls were primiparous.
The infusion of PGF2a (Dinoprost®, 5 mg/1 0,9%
NaCl) was instituted at a rate of 1.5 μg/min and
was increased stepwise to 3.0 μg/min at 30min
and to 6.0 μg/min at 90 min after infusion began.
© by Walter de Gruyter & Co. Berlin · New York
16 Rasmussen et al., Prostaglandin levels and uterine contractions
Tab. I. Indications for induction of labor























The infusion was maintained at 6.0 g/min until
delivery; the infusion was discontinued after
6 hours if progressive labor was not established.
The control group was infused with 0.9% NaCl
for 6 hours. The cervical status was determined at
examinations performed before and at 2, 4, and
6 hours after infusion began. Uterine activity and
fetal well being were recorded with external
electrocardiotocography. Artificial rupture of
membranes was performed when BISHOP score
was 9 or more.
Blood was drawn into heparinized, ice-cooled tubes
before, and 0.5, 1, 2, 4, and 6 hours after infusion
began, always before a vaginal examination. The
blood samples were kept on ice and centrifuged
immediately. The plasma was separated and
acidified. The samples were then stored at — 20°C
until assayed for PGF2a and PGFM with radio-
immunoassays for PGF2Q, and PGFM described
earlier [6, 7]. The prostaglandins were extracted
Tab. II. Clinical characteristics of the patient material.






























with ethylacetate-cyclohexane mixture (1:1)
from plasma acidified to 'pH 4.5. The dried extracts
were purified by silicic acid column chromoto-
graphy (Biosil-A, BIORAD LABORATORIES, Rich-
mond, California) before assay. Separation of
bound and free ligand was done with dextran-
charcoal. The antibody against PGF2a (kindly
donated by Dr. K. KlRTON, the UPJOHN Co.
Kalamazoo, Michigan) cross-reacts almost 100%
with PGFla. The results are therefore expressed as
PGF-like immuno-activity. The PGFM antibody
was also a gift from Dr. K. KlRTON. It cross-reacts
significantly (20%) with 15-keto-PGF2a and has
less than 1% cross-reactivity with PGE2, PGA2,
and their 15-keto and 13,14-dihydro metabolites
and to PGF2cr All solvents were from FISHER
SCIENTIFIC (Fairlawn, New Jersey) and of spec-
tranalyzed grade. Multitritiated PGF2a and PGFM
were used as labeled ligands. They were obtained
from AMERSHAM (Arlington Heights, Illinois).
The detection limits (2 SD away from Bo) were 10
and 12pg/tube for PGF and PGFM respectively.
50% displacement was obtained with 96.2 ± 14.2
and 133 ± 12 pg/tube for PGF and PGFM respec-
tively. Intra-assay variations in the range of 50—
,200pg were 6.8-8.2% and 3.4-6% for PGF and
PGFM respectively and the inter-assay variations at
the 50 pg levels were 18.4% and 8.6% respec-
tively. Blank values due to solvents were deducted
from the final calculations.
Statistical analysis was done by KRUSKAL-WALLIS
nonparametric analysis of variance followed by
DUNNETT's one tailed t-test, p < 0.05 was con-
sidered significant. Results are the mean SD for




Before the infusions began the patients had little
or no uterine activity. In Group A, the mean
frequency expressed as contractions per 10 min
was 0.5 ± 0.5, and in Group B it was 0.1 ± 0.15.
During infusion of PGF^ all patients developed
uterine contractions, with a mean interval to the
onset of increased uterine contractions of
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62.5 ±62.1 min. The median value was 35 min,
range 20 to 210 min. In 2 patients contractions
appeared when the infusion rate was 1.5 μ§/ιηίη,
in 6 patients during infusion at the rate of
3.0 μg/min, and in two after the infusion rate was
increased to 6.0 iig/min. The frequency of con-
tractions then increased rapidly being 2.0 ±2.1 at
1 hour, 2.8 ± 1.8 at 2 hours, and reaching a steady
state of 3.5 ± 0.9 at 3 to 4 hours after infusion
began (Fig. 1).
In the controls uterine activity remained unchanged
in 5 and increased somewhat in one patient (from
1 per 30 min to 2 per 30 min) in the course of the
6 hours observation period.
3.2 Cervical changes
In Group B the BISHOP scores increased from a
mean of 4.2 ± 1.8 before the infusion to 7.3 ± 3.1
at 6 or 8 hours after the PGF2Q! infusion began.
In Group A the change in BISHOP scores in the
course of the 6 hours saline infusion was insignif-
icant (from 4.8 ± 3.0 to 5.0 ± 2.9).
3.3 Outcome of induction: delivery
Five of the 10 patients in Group B delivered
within 24 hours while only 1 in Group A delivered
in less than 24 hours. The mean induction delivery
interval in the 5 successful cases was 11.1 ±7.4
hours. One patient in Group B had to be delivered
by Caesarean section because of fetal distress that
developed during the infusion of PGF2a. The four
remaining patients required further induction and
delivered 36 to 83 hours after the first infusion
began.
In the control group two delivered spontaneously,
22 and 69 hours after saline infusion began, and 4
were induced with PGF2a infusions, and they
delivered within 5 days.
All infants had normal birth weights (mean:
3584 g, range 2900-4850 g) and APGAR scores
with the exception of the infant delivered by
Caesarean section who had APGAR score of 1 at
l min, 6 at 5 min, and 10 at 10 min.
3.4 Plasma prostaglandin levels
The initial level of PGF was 47.0 ± 11.4 pg/ml in
Group A and 37.7 ± 14.4 pg/ml in Group B. No
significant rise was observed in the controls during
the 6 hours infusion of saline (Fig. 1) whereas in
Group B plasma PGF rose over initial levels in all
patients. The rise became significant 2 hours after
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HOURS AFTER INFUSION BEGAN
Fig. 1. Plasma prostaglandin levels before and during infusion of 0.9% NaCl in 6 pregnant women at term (Group A).
PGF: open circles; 13,14-dihydro-15-keto-PGF2o: (PGFM): closed circles; frequency of uterine contractions is also
shown: triangles. Values are mean ± SE.
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infusion of PGF2a began, when the rate was
6 μ§/πιίη. At the lowest rate, 1.5 μ§/πύη, a rise
was not detectable in any of the patients, with
3.0 μ§/ιηίη the PGF levels increased in some but
not all patients. Variations in plasma PGF levels
were considerable even during the constant infu-
sion of 6.0 μg/min. Incidentally the patient who
had uterine hyperstimulation and in whom fetal
bradycardia made Caesarean section necessary,
had the highest PGF level of all, rising to almost
1000pg/ml.
In Group A the concentration of PGFM did not
change during the observation period, the levels
hovered around 150pg/ml (Fig. 1). In Group Β,
the concentration of PGFM rose very rapidly and
was significantly increased 30min after the
infusion of PGF2a began. The levels then increased
in a dose dependent manner reaching a steady
state of over 3 μg/ml at 2 hours (Fig. 2).
4 Discussion
The data presented in this study indicate that at
rates required for uterine stimulation systemic
administration of PGF2a resulted in significant
elevations of plasma PGFM levels, and at rates
inducing labor-like uterine activity even the pri-
mary prostaglandin F2a levels were raised. Both
PGFM and PGF levels far exceeded the concentra-
tions observed during spontaneous labor [6,11] or
oxytocin induced labor [12]. In contrast to the
findings in spontaneous labor, plasma PGFM was
significantly raised over late pregnancy levels
already at or prior to the time when uterine con-
tractile activity began to increase noticeably.
Oxytocin differs from PGF2a in this respect. At
term oxytocin is capable of inducing uterine con-
tractions at infusion rates (1—2mU/min) that do
not raise circulating oxytocin levels singificantiy
PROSTAGLANDIN LEVELS AND UTERINE ACTIVITY
AND CERVICAL DILATATION DURING INDUCTION
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HOURS AFTER INFUSION BEGAN
Fig. 2. Plasma prostaglandin levels before and during i.v. infusion of PGF2a for induction of labor in 10 pregnant
women at term (Group B), symbols as in Figure 1. Open bars represent cervical dilatation at the times indicated. Infusion
rate was increased stepwise from 1.5 Mg/min to 6 Mg/min (stippled horizontal bar).
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over values in late pregnancy plasma [6]. Thus the
responsiveness of the human uterus to oxytocin
increases proportionally more than that to PGF2a
in late pregnancy. A recent report by GlANNO-
POULOS et al. [9] is in agreement with these obser-
vations. They found that the concentration of
uterine PGE and F receptors changed very little
during gestation; by contrast, we have found that
oxytocin receptor concentrations increase about
100 fold from nonpregnant levels f5].
Thus, if prostaglandin F2Q, production is causally
related to the onset of spontaneous labor, the
generation of this prostanoid must take place
locally in the uterine tissues without reaching the
systemic circulation in measurable quantities.
With regard to the clinical outcome of the PGF2a
infusions, the success rate of 50% was much lower
than reported earlier using the same dosage [1].
The reason for this discrepancy may be the greater
proportion of women with low BISHOP scores
(< 4) in the present patient material than in the
earlier report (30% vs 7%) although the correla-
tion with success rate and BISHOP scores was not
significant in the present study. Moreover, amnio-
tomy was not performed until BISHOP score had
reached 9, while in the earlier study [1] amnio-
tomy was performed when cervix was 2 cm dilated
regardless of the BISHOP score, and therefore all
patients had amniotomy.
The cervical scores in the induction failures
showed some improvement at the end of the 6 to
8 hours infusion, but the mean increment, 1.25
points over 8 hours was not very impressive in
spite of strong uterine activity even in these
patients. Induction of labor by means of iv PGF2Q!
infusions in high-risk pregnancies does therefore
not seem to be better than induction by means of
endocervical PGE2 gel application [7, 10, 15]. The
success rate in induction by means of iv infusions
of PGF2a does therefore not justify the inconven-
ience and unpleasant side-effects associated with
the method, in comparison to the minimal side-
effects associated with local application of PGE2
followed by low dose of oxytocin if necessary.
Summary
The concentrations of plasma PGF2a and its main meta-
bolite, 13,14-dihydro-15-keto-PGF2a (PGFM) were
measured in serial samples of blood collected in 10 preg-
nant women at term who were given iv infusions of low
doses of PGF2a for induction of labor. Six other women
served as controls and were given saline infusions. Uterine
contractions began with a mean latency of 62 min in the
PGF2a infused women, in controls uterine activity
remained unchanged. Plasma PGFM levels had increased
significantly 30 min after PGF2a infusion began, rising
thereafter in a dose dependent manner. Plasma PGF2a
also rose reaching a steady state at 2 hours. No significant
changes were observed in the controls. The 6-h infusion
Keywords: Induction of labor, plasma prostaglandin F2a, plasma 13,14-dihydro-15-keto-prostaglandin F2a:, prosta-
glandin F2a, uterine contractions.
resulted in delivery in 5 of the 10 women, in the 5 others
the cervical scores increased only by 1.25 points on the
average and further treatment was needed to achieve
delivery, although prostanoid levels rose to similar levels
in all. The data show that when uterine contractions are
induced by systemic PGF2a, the levels of PGFM are
significantly raised. In spontaneous labor uterine con-
tractions begin long before plasma PGFM rises. Thus, if
endogenous PGF2a generation is involved in the initiation
of uterine contractions during spontaneous labor, it must
be synthetized in the myometrium at quantities too low
to raise the levels of circulating PGFM.
Zusammenfassung
Höhe der PG-F2af und 13,14-dihydro-15-keto-PG-F2Qf
Plasmaspiegel bei Geburtseinleitungen mit PG-F2a-
Infusionen in Relation zur Wehentätigkeit
Wir bestimmten die Plasmakonzentrationen von PGF2a
und 13,14-dihydro-15-keto-PGF2a (PGFM) als Haupt-
metabolit in mehreren Blutproben von 10 Frauen am Ter-
min. Sie erhielten zur Geburtseinleitung Infusionen mit
PGF2ain niedriger Dosierung. Die Kontrollgruppe bestand
aus 6 Frauen, bei denen NaCl infundiert wurde. Die
Wehentätigkeit setzte bei PGF2a-Infusion nach einer
mittleren Latenzzeit von 62 Minuten ein. In der Kontroll-
gruppe waren keine Veränderungen zu beobachten. Der
PGFM-Spiegel zeigte 30 Minuten nach Beginn der PGF2a-
Infusion einen signifikanten Anstieg, danach war der
Anstieg dosisabhängig. Auch die PGF2o,-Spiegel stiegen
an und erreichten nach 2 Stunden einen Steady-state. In
der Kontrollgruppe kam es wiederum nicht zu Verände-
rungen. Eine Infusion über 6 Stunden führte bei 5 der
10 Frauen zur Entbindung. Bei den anderen 5 Frauen
änderte sich der Zervix-Score um durchschnittlich 1,25
J. Perinat. Med. 13 (1985)
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Punkte, so daß eine weitere Behandlung notwendig war.
Der Anstieg der PG-Spiegel war jedoch ähnlich wie bei
den übrigen Verläufen. Unsere Ergebnisse zeigen, daß bei
einer Wehentätigkeit, die durch systemische PGF2QfGabe
induziert wurde, die PGFM-Spiegel signifikant ansteigen.
Bei Spontangeburten beginnt die Wehentätigkeit lange vor
dem Anstieg der PGFM-Plasmaspiegel. Wenn eine endo-
gene PGF2a-Bildung bei der Induktion der Wehentätigkeit
bei Spontangeburten beteiligt ist, muß PGF2a im Myo-
metrium synthetisiert werden, und zwar in Mengen, die zu
klein sind, um die Spiegel des zirkulierenden PGFM anzu-
heben.
Schlüsselwörter: Geburtseinleitung, Prostaglandin F2a im Plasma, 13,14-dihydro-15-ketoprostaglandin F2a im Plasma,
Prostaglandin F2a, Wehentätigkeit.
Resume
Taux plasmatiques de prostaglandines F2a et de 13,14-
dihydro-15-ceto-prostaglandines F2a chez les femmes en
cours d'induction de travail par perfusion i.v. de prosta-
glandines F2a, relations avec les contractions uterines
On a mesure les concentrations plasmatiques de PGF2a et
de son metabolite principal, la 13,14-dihydro-ceto-
PGF2a (PGFM) dans des echantillons sanguins preleves en
serie chez 10 femmes enceintes ä terme dont le travail
etait declenche par des perfusions de faibles doses de
PGF2a. Six autres femmes on servi de contröles et on
regu des perfusions de serum sale.
Les contractions uterines ont debute au bout d'un temps
de latence moyen de 62 minutes chez les femmes recevant
les PGF2a, tandis que chez les temoins, 1'activite uterine
est demeuree inchangee.
Le taux plasmatique de PGFM s'est eleve de fagon signifi-
cative 30 minutes apres le debut de la perfusion dePGF2Q,,
avec une elevation ulterieure dose dependante.
Les PGF2a se sont aussi elevees pour atteindre un plateau
stable au bout de 2 heures.
Les 6 heures de perfusion ont permis 1'accouchement chez
5 femmes sur 10, chez les 5 autres les scores cervicaux ne
se sont ameliores en moyenne que de 1,25 points et un
traitement supplemental a ete necessaire pour obtenir
1'accouchement bien que les taux de prostanoides se
soient eleves de faqon similaire chez toutes les femmes.
Les donnees montrent que quand les contractions uterines
sont induites par des PGF2Q! systemiques les taux de
PGFM s'elevent de faqon significative.
Lors du travail spontane, les contractions uterines com-
mencent longtemps apres Felevation plasmatique de
PGFM.
De teile sorte que, si implique la synthese de PGF2a
endogenes dans initiation des contractions ut6rines
relatifs aux accouchements spontanes, ces prostaglandines
endogenes doivent etre synth€tis6es dans le myomfetre en
quantiti assez faible pour ne pas £lever les taux de PGFM
circulantes.
Mots-cles: Contractions uterines, declenchement du travail, prostaglandines F2a, prostaglandines F2a plasmatiques,
prostaglandines 13,14-dihydro-15-ceto-prostaglandines F2a plasmatiques.
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